Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition • 09-14 May 2026
| 16:00 |
|
608-03-001.
A Travelling Kidney and Repeatability Study using the harmonised UKRIN-MAPS multiparametric renal MRI protocol
Impact: Harmonisation and standardisation is crucial
for multi-centre evaluation and clinical translation of renal MRI measures. We
demonstrated the UKRIN-MAPS acquisition and analysis pipeline provides good
inter- and intra-session CV, essential for the interpretation of future
multi-centre trials in kidney disease.
|
|
| 16:11 |
|
608-03-002.
High-resolution highly accelerated free breathing 3D joint T1/T2 and PDFF/T2* mapping of the liver at 0.55T
Impact: High-resolution free breathing 3D joint T1/T2 and 3D joint PDFF/T2* mapping of the entire liver is feasible with two 3D acquisitions
in a total scan time of ~9 min at 0.55T enabling more affordable
and comprehensive assessment of liver
disease.
|
|
| 16:22 |
|
608-03-003.
Efficacy of Single Breath-hold Multi-echo 3D-QALAS for Robust Quantitative Abdominal MRI
Impact: Single breath-hold multi-echo 3D-QALAS synthetic T1, T2, T2*, and fat fraction parametric maps in abdominal MRI are not interchangeable with their conventional parametric
sequence counterparts except for PDFF from Dixon. Sequence timings need
optimization to capture wider tissue relaxation times.
|
|
| 16:33 |
|
608-03-004.
Multiparametric qMRI of Peripheral Nerves: Diagnostic Differentiation and Biomarker Development in Polyneuropathies
Impact: Multiparametric qMRI of proximal nerves reliably differentiates between demyelinating and axonal polyneuropathies, which could complement nerve conduction studies on distal nerves for diagnosis. The composite qMRI score could be a non-invasive biomarker candidate for monitoring disease progression.
|
|
| 16:44 |
|
608-03-005.
T1 and T2 mapping of the human brain across magnetic field strengths from 0.047 T to 7.0 T
Impact: Measuring T₁
and T₂ in the same
subjects from 0.047T to 7.0T on the same software
allows more
rigorous determination of the dependency on field strengths, which in turn aids in contrast
optimization for mid- and low-field MRI.
|
|
| 16:55 |
|
608-03-006.
MWF-MIMOSA for Highly-efficient Joint Relaxometry and Myelin Water Fraction Mapping
Impact: MWF-MIMOSA enables whole-brain T1, T2, T2*, PD, QSM, susceptibility source separation, and MWF mapping at 1 mm3 resolution in 5 minutes, achieving simultaneous relaxometry and myelin water fraction mapping in a single scan for comprehensive tissue characterization.
|
|
| 17:06 |
|
608-03-007.
Whole-Brain Mapping of Formaldehyde Fixation Using Multiparametric MRI
Impact: Multiparametric
MRI enables whole-brain tracking of spatially heterogeneous formaldehyde
fixation in postmortem tissue. Validated by gross dissection of brain specimen,
T1-based measures are most sensitive to different fixation stages, which can
non-invasively monitor fixation progression before dissection or histological
sampling.
|
|
| 17:17 |
|
608-03-008.
Clinical Acquisition of Joint T1-T2 Contrast-Encoded MRI at 0.064T
Impact: Achieving
joint T₁–T₂ encoding in vivo at 64 mT establishes a foundation for
future multi-dimensional MRI studies on portable low-field scanners. This
capability enables new scientific questions about tissue composition and
supports wider deployment of quantitative imaging in resource-limited
environments.
|
|
| 17:28 |
|
608-03-009.
Resolving and Quantifying Subvoxel Tissue Components in Multidimensional MRI for Clinical Translation
Impact: By disentangling signals from subvoxel tissue components with distinct MR-relaxation and diffusion properties, we
enable more specific and reproducible quantitative imaging biomarkers. This approach can
improve clinical diagnostic sensitivity and open new avenues for
investigating tissue heterogeneity and microstructural pathology.
|
|
| 17:39 |
|
608-03-010.
Dipolar order mapping based on spin-lock magnetic resonance imaging
Impact: We propose a spin-lock MRI method for T1D quantification, providing a sensitive assessment of myelin microstructural integrity. It has the potential to improve understanding of myelin-related mechanisms and serve as a biomarker for neuroprotection and repair in clinical trials.
|
© 2026 International Society for Magnetic Resonance in Medicine